AKT1 and tuberculosis: Furthermore, TB supplementation activates PI3K/Akt/Nrf2 and inhibits the NF-κB signaling pathway, regulating antioxidant capacity and the inflammatory response and preventing hepatic and intestinal damage (Figure 9).